Intermediate to high risk PE represents a clinical challenge owing to the heterogeneity of presentation. A key decision faced by clinicians is whether reperfusion therapy is required. Rational decision making involves consideration of urgency of reperfusion therapy, available modalities for reperfusion therapy, and bleeding risk. There remains major gaps in the current literature to guide optimal therapy. This talk will present a respiratory physician's perspective on when to consider reperfusion therapy in acute PE.